In this series, ‘Genomics 101’, we go back to basics and explore some of the most important topics in genomics. In this blog, we talk through the difference between RNA and DNA.
Genomics 101: RNA vs DNA, what's the difference?
In this series, ‘Genomics 101’, we go back to basics and explore some of the most important topics in genomics. In this blog, we talk through the difference between RNA and DNA.
Genomics 101: RNA vs DNA, what's the difference?
In part 2 of this series, Genome Data Scientists Olena and Nadezda discuss our approach to variant recovery in incidences of contaminated normal samples during somatic variant detection.
Tumour in normal contamination (TINC) Part 2: Approaching variant recovery
A recent study analysing genetic and clinical data from over 13,000 people with cancer has shown the benefits of using genomics in routine care.
Another step closer to personalised cancer care
The NDRS is a valuable data source for cancer researchers. A team at Genomics England have been mapping NDRS data to a common model, making it widely accessible for approved researchers.
Expertise, experience, and endurance: mapping NHS cancer records to a common data model
As part of our Cancer 2.0 initiative we're building the world's largest whole genome sequence multimodal cancer research platform - combining genomic, clinical and imaging data.
Launching a global standard resource for cancer research
Sunandini Ramnarayanan shares how the National Genomic Research Library is supporting her to understand the role of 'DNA dark matter' in cancer.
Researcher on the rise: Sunandini Ramnarayanan